Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
30 January 2015
Header
Header image
Highlight of the week

Events Calendar

Going Live: Implementation of the Disclosure Code
On 29/01/2015 (Rotterdam)

On January 29th, Pharmadiscolsure.eu, the multi-stakeholder initiative supported by EFPIA, held a roundtable highlighting the implementation of EFPIA’s Responsible Transparency initiative. Hosted in Rotterdam by EFPIA’s Dutch association NEFARMA, the roundtable was part of a public information campaign launched to boost pharmaceutical industry preparedness in complying to new disclosure rules for certain financial and other transfers of value with healthcare professionals and organisations.

Discussion topics at the event included the successful multi-stakeholder implementation of transparency processes in the Netherlands, as well as the steps to implementation being undertaken in Poland and Germany.

The detailed event report will be released in the course of next week.

Read more

News

News

EFPIA launches new resources on speeding up the development of, and access to, new medicines
27 January 2015

Medicines Adaptive Pathways to Patients (MAPPs) are flexible development and access pathways within the current regulatory framework that balance early patient access, public health and societal [...] Read more

News

Collaboration is the key to managing pharmaceuticals in the environment
29 January 2015

(29 January 2015 – Brussels): Health Care Without Harm (HCWH) Europe and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have come together to [...] Read more

News

The European Patient Academy is recruiting for its second round of training for Patients Experts in Medicines R&D
26 January 2015

EUPATI is now accepting applications until 31 March 2015 for the second cycle of the EUPATI Expert Patient Training Course kicking off in the fall [...] Read more

From our blog

From our blog

Taking the next step in the fight to take doping out of sport
30 January 2015 by Richard Bergström

Cutting edge technologies like the identification of biomarkers, data collection, pharmacovigilance, patient compliance and analytical tools, advances in genomics and the use of stem cells save patient lives everyday, but we hope they can also enable the fight against doping.

Read more

What we are reading

What we are reading

Execs say FDA should review clinical AND economic value
30 January 2015 (Pharma Times)

A new report from PwC claims that over 40% of pharmaceutical and life sciences senior executives support the idea of the US Food and Drug Administration evaluating drugs based on both clinical and economic effectiveness.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail